GT Biopharma (GTBP) P/E (2017 - 2026)
GT Biopharma (GTBP) P/E from Sep 22, 2017 to Jul 21, 2026. The TTM GT Biopharma (GTBP) P/E is -0.27. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of GT Biopharma (GTBP)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.27 | -5.09% |
| 2025 | -0.28 | -40.40% |
| 2024 | -0.47 | +15.98% |
| 2023 | -0.41 | -71.21% |
| 2022 | -1.42 | -70.96% |
| 2021 | -4.88 | -57.69% |
| 2020 | -11.53 | +462.46% |
| 2019 | -2.05 | -4.17% |
| 2018 | -2.14 | -92.26% |
| 2017 | -27.63 | N/A |
Comparison GT Biopharma (GTBP) P/E with competitors
GT Biopharma (GTBP) P/E is -0.27.